Skip to content

Clinical study of Fangxia Dihuang Decoction intervention on psychosomatic symptoms of breast cancer patients undergoing chemotherapy

Clinical study of Fangxia Dihuang Decoction intervention on psychosomatic symptoms of breast cancer patients undergoing chemotherapy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005877
Enrollment
Unknown
Registered
2022-04-17
Start date
2022-06-06
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

control group:Fangxia Dihuang Decoction

Sponsors

Xiamen Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Women aged 18-70; (2) Postoperative pathological diagnosis of breast cancer, clinical stage II to III; (3) Postoperative adjuvant chemotherapy is planned; (4) ECOG score 0-2; (5) Consistent with the TCM syndrome diagnosis of liver and kidney Yin deficiency, blood stasis and heat disturbing the spirit; (6) Sign informed consent to participate in this study voluntarily.,

Exclusion criteria

Exclusion criteria: (1) complicated with serious diseases of the heart, cerebrovascular, liver, kidney, hematopoietic system or other malignant tumors; (2) people who are allergic to the study drugs; (3) those who do not know the diagnosis of breast cancer; (4) with a history of serious mental disorders; (5) Have received psychological treatment or psychological intervention in the past three months; (6) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire Depression Module;Generalized Anxiety Disor-der Scale;

Secondary

MeasureTime frame
Chinese medicine symptom complex score;Brief Fatigue Inventory-Chinese;Prospective and Retrospective Memory Questionnaire;Athens Insomnia Scale;

Countries

China

Contacts

Public ContactPei Xiaohua
pxh_127@163.com13911683278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026